Eccrine Porocarcinoma: New Insights and a Systematic Review of the Literature
Overview
Affiliations
Background: Eccrine porocarcinoma (EPC) is a rare cutaneous neoplasm with high potential for morbidity and mortality. Due to its rarity, there is a paucity of data profiling diagnosis, work-up, and management.
Objective: To consolidate reported information on demographics, diagnostics, clinical behavior, treatment modalities, and patient outcomes in EPC to provide a reference tool to optimize diagnosis and management.
Methods: A comprehensive PubMed search was performed from 1963 to November 2017 using PRISMA guidelines. This yielded 155 articles detailing 206 cases of porocarcinoma.
Results: Eccrine porocarcinoma most often presents in elderly patients on the head and neck or lower limbs. Metastatic disease at presentation is not uncommon (22%). Primary tumor location is significantly correlated with presence of metastasis (p = .038). The most common treatment is excision followed by Mohs micrographic surgery (MMS), although the outcomes after MMS were superior to those after surgical excision.
Conclusion: This systematic review of individual patient data reveals that all patients should have a histological diagnosis with imaging considered for high-risk cases. Primary tumor location should also be considered in diagnostic and therapeutic decision-making. Although wide local excision (WLE) is currently the first-line treatment, MMS is becoming increasingly used, with evidence indicating improved outcomes as compared to those seen with WLE.
Eccrine malignancies in nevus sebaceus: Case presentation and review of the literature.
Woods A, Liu W, Krunic A JAAD Case Rep. 2025; 57:59-63.
PMID: 40027430 PMC: 11869964. DOI: 10.1016/j.jdcr.2024.12.029.
Puttonen M, Almusa H, Bohling T, Koljonen V, Sihto H Orphanet J Rare Dis. 2025; 20(1):70.
PMID: 39948683 PMC: 11823087. DOI: 10.1186/s13023-025-03586-7.
Sentinel Lymph Node Biopsy: Is There a Role in Non-Melanoma Skin Cancer? A Systematic Review.
Borgognoni L, Susini P, Gerlini G, Brandani P, Giannotti V, Sestini S Cancers (Basel). 2025; 16(24.
PMID: 39766177 PMC: 11674682. DOI: 10.3390/cancers16244279.
Diagnosis and Management of Malignant Epithelial Nail Unit Tumors.
Iorizzo M, Vollono L, Richert B Diagnostics (Basel). 2024; 14(21).
PMID: 39518347 PMC: 11545385. DOI: 10.3390/diagnostics14212379.
Bienstman T, Guvenc C, Garmyn M Int J Mol Sci. 2024; 25(11).
PMID: 38891945 PMC: 11172007. DOI: 10.3390/ijms25115760.